RAFAEL HOLDINGS, INC. Proceeds from Issuance of Warrants
RAFAEL HOLDINGS, INC. (RFL) had Proceeds from Issuance of Warrants of $5.00 million as of 2023-08-01, per its 10-K/A filed 2024-12-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2024-12-20
- RAFAEL HOLDINGS, INC. proceeds from issuance of warrants for the quarter ending 2019-01-31 was $0.00.
- RAFAEL HOLDINGS, INC. proceeds from issuance of warrants for the quarter ending 2018-10-31 was $5.00M.
| Period end | Proceeds from Issuance of Warrants | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month |
|---|---|---|---|
| 2023-08-01 | $5.00M 10-K/A · filed 2024-12-20 | ||
| 2023-05-02 | $2.10M 10-K/A · filed 2024-12-20 | ||
| 2019-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-03-12 | $5.00M 10-Q · filed 2019-03-12 | |
| 2018-10-31 | $5.00M 10-Q · filed 2018-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |